Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

ATAZANAVIR SULFATE

ATAZANAVIR SULFATE

Standard Dose
150MG
Max Dose
Refer to approved labeling
Primary Use
Marketing status: None (Tentative Approval)
Summary

Approval overview ATAZANAVIR SULFATE is listed in Drugs@FDA under application 091611 (ANDA).

Marketing status: None (Tentative Approval) Active ingredient ATAZANAVIR SULFATE Form and strength CAPSULE; ORAL - 150MG Sponsor MATRIX LABS LTD Submission history Latest submission status date: 2010-09-15 00:00:00.

Structured Monograph

Clinical summary

Approval overview ATAZANAVIR SULFATE is listed in Drugs@FDA under application 091611 (ANDA). Marketing status: None (Tentative Approval) Active ingredient ATAZANAVIR SULFATE Form and strength CAPSULE; ORAL - 150MG Sponsor MATRIX LABS LTD Submission history Latest submission status date: 2010-09-15 00:00:00. Submission type: ORIG.

Monitoring

  • • Marketing status: None (Tentative Approval)

Interaction Notes

  • No interaction notes stored yet.